Method for isolation of circulating cells from peripheral blood

Photo: illustrative/pixabay.com

Unique system for in vivo isolation of circulating tumor cells (CTCs) from peripheral blood. Technology takes advantage of magnetic nanoparticles coated with a monoclonal antibody that are injected into the bloodstream via an intravenous cannula, as well as of a special wire comprising a magnetic core coated with a non‐magnetic mantle.

Competitive advantage

  • isolation of CTCs and/or CSCs from the whole volume of patient’s blood;
  • in vivo isolation of CTCs and/or CSCs;
  • detection of CTCs and/or CSCs in very low concentrations;
  • more effective than available solutions;
  • universal solution that may be adapted to any type of blood cells;
  • easy and straightforward manipulation.

Use of technology

  • in molecular diagnostics of cancer and personalised medicine.

For download

Protection of intellectual property

  • Granted patents: (SK) (EP)
Back